Browse by Poster Title

Type here to filter the list

Sort by#

Sort byTitle

2
66
2 Methyl-AP-237 Overdose: A Case Report
A
24
A Multipronged Approach to Improving Linkage to Outpatient Substance Use Treatment
108
A Prescription Digital Therapeutic for OUD: 36-Week Real-World Clinical Data
37
Adolescent Addiction Medicine Tele-Consult Services within School-Based Health Centers
38
Adolescent Substance Use: A Mixed Methods Assessment
53
Adopting a Buprenorphine Precision Dosing Approach Treatment for Hispanic Puerto Ricans
41
Advancing Patient-Centered Research and Care Through Journey Mapping: EMPOWER Project
59
Adverse Childhood Experiences are Associated with Overdose History in Outpatient SUD Care
60
Alcohol Use in Primary Care: It’s Time to Ask
58
ASAM Levels of Care in a Specialty OB/GYN Clinic
62
Assessment of COVID-19 Driven Changes in an Integrated OBGYN Addiction Treatment Clinic
42
Association Between Healthcare Costs and MOUD Treatment Linkage for Medicaid FFS Enrollees
63
AUD Readmission Risk Lower With Pre-Discharge Ketamine Infusion or Naltrexone Injection
64
Availability of Buprenorphine-Naloxone in Outpatient Pharmacies in South Florida
B
65
Beyond Trauma-Informed Care: Insights from a Qualitative Study
16
Buprenorphine Pre-Hospital: A Review of 3 Years of MAT Induction by EMS
67
Buprenorphine Rapid Microdosing for Opioid Use Disorder Treatment in the Outpatient Setting
32
Buprenorphine Treatment Disparities: The Role of the Specialty System and Insurance Status
C
33
Cannabis Legalization and Adolescent Substance Use
4
Cannabis-Induced Atypical Stress Cardiomyopathy: A Case Report
68
Change the Conversation: Addiction Mentoring is Key in Palliative Care Training
69
Circumstances Around Cigarette Use After Enforced Smoking Abstinence in an American Prison
70
Clinical Guide to Phenibut: Systematic Review of Intoxication, Withdrawal, and Management
71
Cognitive, Behavioral, and Emotional Outcomes of Severe Cannabis Use in Adolescents
36
Community-Based Interventions for OUD in Black Churches: A Qualitative Study
35
Comparing In-Person and Remote Substance Use Treatment Outcomes Before and During COVID-19
49
Comparing Outcomes of mOUD Maintenance vs. Detoxification in Pregnant Patients with OUD
29
COVID-19 Implications in Mental Health and Opioid Use Disorder Treatment: Qualitative Study
31
COVID-19 Vaccine Uptake and Attitudes Among People with OUD
40
Critical Incidents in Colorado OTPs: Comparing Early COVID-19 Pandemic to Previous Years
D
110
Decreased Stigma & Increased Health Equity through SUD Focused Nurse Practitioner Education
111
Disparities in Naloxone Prescriptions During the COVID-19 Pandemic
E
14
Epigenetic Clocks in Brain and Blood of Individuals with Substance Use Disorder
45
Evaluating Disparities in Prescribing of Naloxone After Treatment of Opioid Overdose
1
Expanded Protective Custody Laws Did Not Increase EMS Transport After Opioid Overdoses
112
Exploring the Association Between Political Affiliation and Alcohol Control Policies
90
Extended-Release Buprenorphine for Opioid Use Disorder: A Cost-Effectiveness Analysis
F
91
Factors Associated With Non-Fatal Overdose Among Patients Enrolled in the OPTIMA Trial
25
Family Dependency Drug Court Service Modifications During COVID-19
H
26
Health Care Utilization Outcomes of a Comprehensive Program for Perinatal Substance Use
88
Higher Buprenorphine Dose Associated with Treatment Retention at Low-Threshold Clinic
I
92
Impact of a Pharmacist-Initiated Naloxone Dispensing Program in Community Pharmacies
61
Impact of an Alcohol Withdrawal Screening and Treatment Protocol for Hospitalized Patients
93
Impact of Prenatal Cannabis Use on Maternal and Neonatal Outcomes
47
Implementing Substance Use Prevention Programming in Rural Utah During COVID-19
15
Improving Intranasal Naloxone Distribution for Harm Reduction in Emergency Departments
94
In Hospital Addiction Treatment Reduces Readmissions for Patients with Related IE
73
Increasing Naltrexone Prescriptions for Hospitalized Patients with Alcohol Use Disorder
95
Individual and Population Opioid Use Disorder Needs: A Multi-State ASAM Criteria Database
10
Individuals Diagnosed with an Alcohol Use Disorder: Who Receives What Healthcare Advice?
89
Infective Endocarditis in People Who Use Drugs: A Critical Review of Guidelines
79
Interventions Addressing Marijuana Use During Pregnancy: A Systematic Review
2
Intravenous Buprenorphine for Opioid Withdrawal: A Case Series
K
11
Kratom (Mitragyna speciosa) and Polysubstance Use Patterns: A Latent Class Analysis
72
Kratom Use in Pregnancy
L
21
Leveraging Community in Addiction Recovery for Permanent Supportive Housing Residents
83
Long-Term Treatment Benefit of BUP-XR for Patients Struggling to Abstain from Opioids
81
Low-Barrier Group Medical Visits for Substance Use Disorder
M
9
Mammography Screening Disparities in Urban Patients with Substance Use Disorder
50
Medical Mistrust and Care Expectations Among Black Patients Seeking Addiction Treatment
43
Medication for Opioid Use Disorder Amongst People of Color in Residential Treatment
82
Mothers’ Knowledge, Attitudes, and Perception Regarding Extended-Release Buprenorphine
74
Multimodal Pain Management in a Patient Taking Extended-Release Buprenorphine
N
7
Naltrexone Prescribing from the Emergency Department
22
New OTP Patient Retention Was Unchanged by COVID Take Home Methadone Increases
O
84
On-Demand, Audio-Only Buprenorphine Initiation During COVID-19
48
Opioid Agonist Therapy Improves HIV/TB Outcomes Among PWUD/PWID in Mbeya, Tanzania
85
Opioid Overdoses During the 2020 COVID-19 Pandemic
34
Opioid Use Disorder Treatment Training Impacts Future Residents’ Attitudes and Perceptions
86
Outcomes of a Robust Addiction Medicine Curriculum in Undergraduate Medical Education
P
109
“P.O. Buprenorphine” - An Alternative Method of Buprenorphine Initiation: A Case Report
23
Patient Attitudes Toward Open Label Placebo Treatment for Opioid Use Disorder
87
Patients’ Satisfaction With Methadone and Buprenorphine
77
People Who Inhale Stimulants At Risk for COVID-19 and Other Injury
96
Perinatal Opioid Use Disorder: Postpartum Access to Healthcare and Opioid Use Treatment
97
Physician Assistant Students’ Perceptions of Substance Use Disorders
75
Pilot Survey of SBIRT and Sexual Activity: Outpatient Providers’ Comfort Levels Vary
76
Police Response to Opioid Overdoses: Impact on Future Contacts, Incarceration and Overdose
12
Predictors of Buprenorphine Continuation Among Postpartum People With Opioid Use Disorder
98
Predispositions of Living with Disability During COVID-19
99
Prenatal Opioid Use: High Stakes Game In Need of a Team Approach
54
Pre-Paid Phone Distribution to People With Substance Use Disorder
57
Prescribing Medication Assisted Therapy After Admission For Alcohol Withdrawal Syndrome
5
Prevalence and Predictors of MAT Among Reproductive-Aged Women
28
Project BETTER Acceptability: Technology-Based Educational Intervention for Women on MOUD
R
46
Race and Ethnicity Concordance in Recovery Coaching
27
Real-world Evaluation of an Injectable Extended-Release Buprenorphine Program
18
Real-World Outcomes With MOUD in Uninsured Patients: Inpatient to Outpatient Transitions
8
Relief Is Hard to Reach: Barriers to Medical Cannabis in Bronx, NY
100
Results From a Pilot Study Evaluating a Novel Naloxone Nasal Swab
101
Right Treatment Right Time: ED MOUD in a Single Safety-Net Hospital System
17
Rural and Urban Michigan Pharmacists’ Perceptions of Buprenorphine for Opioid Use Disorder
102
Rural Versus Urban SSP Utilization in Maine: A Harm Reduction Study
S
52
Services for Treatment of Chronic Pain at Residential Substance Abuse Treatment Centers
13
Social Determinants of Health & Substance Use Disorder Treatment: Scoping Literature Review
6
Substance Abuse Research Education and Training Program (SARET)
19
Successfully Enrolling a Prospective Cohort With Opioid Use Disorder and Serious Infections
103
Surface Based Morphometry (SBM) in Opioid Use Disorder: A Controlled Study
80
Syringe Exchange Services in Primary Care
T
56
The Epidemiology of Pre-Hospital Care for Opioid Overdoses in a US-Border Town
51
The Female Offender Re-Entry Movement (FOR-Me): Increasing Access to SUD treatment
55
The Impacts of the COVID-19 Pandemic on Syringe Service Program Staff Wellbeing
104
The New and Dynamic Nature of the Opioid Epidemic
105
Transcranial Electrical Stimulation in Meth Craving: A Mechanistic Dose-Response RCT
106
Trauma, Resiliency, and Longitudinal Treatment Outcomes in a Pediatric MAT Clinic
107
Treatment Experience of Previously Incarcerated People In Outpatient Methadone Treatment
44
Trends in Buprenorphine Treatment Disparities During the COVID Pandemic in Massachusetts
30
Triangulating Substance Use, Treatment, and Mortality Trends Using Multiple Sources
113
Two Cases of Rapid Titration of Methadone in the Hospital Setting
U
20
U.S. County Jail Care of Incarcerated Pregnant Persons with Opioid Use Disorder
78
Under One Roof – An Integrated Clinic for SUD and HCV/HIV Treatment
3
Using Academic Detailing for Educational Outreach to Reduce Opioid Prescribing Rates
39
Using NCCN Recommended Tool to Screen for Opioid Misuse in Cancer Patients: Are We Overdiagnosing Addiction?